477 related articles for article (PubMed ID: 23886215)
1. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
Ishtiaq S; Hassan U; Mushtaq S; Akhtar N
Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215
[TBL] [Abstract][Full Text] [Related]
2. Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters.
Hashmi AA; Hussain ZF; Hashmi KA; Zafar MI; Edhi MM; Faridi N; Khan M
World J Surg Oncol; 2017 Apr; 15(1):89. PubMed ID: 28427406
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age?
Monabati A; Vahedi A; Safaei A; Noori S; Mokhtari M; Vahedi L; Zamani M
Asian Pac J Cancer Prev; 2016; 17(4):2285-9. PubMed ID: 27221931
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin's lymphomas in Khorasan, northeast of Iran.
Abadi RZ; Sistani NS; Mohtasham N; Hesari KK; Vaezi T; Pazouki M; Shakeri MT
J Pak Med Assoc; 2013 Jul; 63(7):882-7. PubMed ID: 23901714
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of Epstein-Barr virus infection and childhood lymphoma].
Xie ZD; Wang L; Lu D; Zhou CJ; Shen KL
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):365-7. PubMed ID: 18953837
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
9. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
[TBL] [Abstract][Full Text] [Related]
11. Frequency of epstein-barr virus in classical hodgkin Lymphoma.
Azhar M; Din HU; Muhammad I; Hashmi SN; Akhtar F
J Ayub Med Coll Abbottabad; 2016; 28(2):271-275. PubMed ID: 28718560
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus in biopsies from patients with Hodgkin and non-Hodgkin lymphoma at the University of Puerto Rico immunohistochemistry laboratory.
Córdova Pérez FJ; González-Keelan CI; Vélez R
P R Health Sci J; 2003 Jun; 22(2):125-9. PubMed ID: 12866135
[TBL] [Abstract][Full Text] [Related]
13. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
14. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications.
Volaric AK; Saleem A; Younes SF; Zhao S; Natkunam Y
Ann Diagn Pathol; 2024 Jun; 70():152286. PubMed ID: 38447253
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas.
Kim SJ; Hyeon J; Cho I; Ko YH; Kim WS
Cancer Res Treat; 2019 Apr; 51(2):611-622. PubMed ID: 30025443
[TBL] [Abstract][Full Text] [Related]
17. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina.
Chabay PA; De Matteo EN; Aversa L; Maglio S; Grinstein S; Preciado MV
Arch Pathol Lab Med; 2002 Mar; 126(3):331-5. PubMed ID: 11860309
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital.
Karnik S; Srinivasan B; Nair S
Pathology; 2003 Jun; 35(3):207-11. PubMed ID: 14506963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
